Is Option B+ the best choice?

PubWeight™: 6.17‹?› | Rank: Top 1%

🔗 View Article (PMID 23351797)

Published in Lancet on January 26, 2013

Authors

Anna Coutsoudis1, Ameena Goga, Chris Desmond, Peter Barron, Vivian Black, Hoosen Coovadia

Author Affiliations

1: Department of Paediatrics and Child Health, University of KwaZulu-Natal, South Africa.

Associated clinical trials:

Postpartum Adherence Clubs for Antiretroviral Therapy (PACART) | NCT03200054

Articles citing this

Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi. AIDS (2014) 5.43

Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review. J Int AIDS Soc (2013) 2.82

A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women. PLoS One (2014) 1.44

Lessons learned from early implementation of option B+: the Elizabeth Glaser Pediatric AIDS Foundation experience in 11 African countries. J Acquir Immune Defic Syndr (2014) 1.42

Women's preferences regarding infant or maternal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV during breastfeeding and their views on Option B+ in Dar es Salaam, Tanzania. PLoS One (2014) 1.37

Is Option B+ the best choice? Lancet (2013) 1.26

Is Option B+ the best choice? Lancet (2013) 1.24

A systematic review of health system barriers and enablers for antiretroviral therapy (ART) for HIV-infected pregnant and postpartum women. PLoS One (2014) 1.21

Is Option B+ the best choice? Lancet (2013) 1.18

Attitudes of people in the UK with HIV who Are Antiretroviral (ART) Naïve to starting ART at high CD4 counts for potential health benefit or to prevent HIV transmission. PLoS One (2014) 1.17

HIV and the risk of direct obstetric complications: a systematic review and meta-analysis. PLoS One (2013) 1.16

Is Option B+ the best choice? Lancet (2013) 1.16

Reassuring Birth Outcomes With Tenofovir/Emtricitabine/Efavirenz Used for Prevention of Mother-to-Child Transmission of HIV in Botswana. J Acquir Immune Defic Syndr (2016) 1.00

Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program. Clin Infect Dis (2016) 0.97

Fundamental concerns of women living with HIV around the implementation of Option B. J Int AIDS Soc (2015) 0.96

Global response to HIV: treatment as prevention, or treatment for treatment? Clin Infect Dis (2014) 0.94

Is Option B+ the best choice? Authors' reply. Lancet (2013) 0.94

Universal combination antiretroviral regimens to prevent mother-to-child transmission of HIV in rural Zambia: a two-round cross-sectional study. Bull World Health Organ (2014) 0.92

Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3. PLoS One (2017) 0.83

Evolution of antiretroviral therapy services for HIV-infected pregnant women in Cape Town, South Africa. J Acquir Immune Defic Syndr (2015) 0.81

Evidence and AIDS activism: HIV scale-up and the contemporary politics of knowledge in global public health. Glob Public Health (2014) 0.80

Messages on pregnancy and family planning that providers give women living with HIV in the context of a Positive Health, Dignity, and Prevention intervention in Mozambique. Int J Womens Health (2014) 0.78

Preventing Mother To Child Transmission of HIV - Current strategies. Med J Armed Forces India (2014) 0.77

Tracing defaulters in HIV prevention of mother-to-child transmission programmes through community health workers: results from a rural setting in Zimbabwe. J Int AIDS Soc (2015) 0.75

Prevention of mother-to-child transmission in South Africa: an ever-changing landscape. Obstet Med (2015) 0.75

Trends in ART Initiation among Men and Non-Pregnant/Non-Breastfeeding Women before and after Option B+ in Southern Malawi. PLoS One (2016) 0.75

Sexual and reproductive health and human rights of women living with HIV. J Int AIDS Soc (2015) 0.75

Pursuing ethical coherence in the prevention of vertical transmission of HIV: justice and injustice in Option B. J Virus Erad (2017) 0.75

"If donors woke up tomorrow and said we can't fund you, what would we do?" A health system dynamics analysis of implementation of PMTCT option B+ in Uganda. Global Health (2017) 0.75

Awareness and perceived fairness of Option B+ in Malawi: A population-level perspective J Int AIDS Soc (2017) 0.75

Articles by these authors

Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet (2004) 16.28

CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med (2006) 10.34

The health and health system of South Africa: historical roots of current public health challenges. Lancet (2009) 7.76

Sub-Saharan Africa's mothers, newborns, and children: where and why do they die? PLoS Med (2010) 5.54

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis (2003) 4.49

Achieving the health Millennium Development Goals for South Africa: challenges and priorities. Lancet (2009) 3.35

Exclusive breastfeeding promotion by peer counsellors in sub-Saharan Africa (PROMISE-EBF): a cluster-randomised trial. Lancet (2011) 3.21

Sub-Saharan Africa's mothers, newborns, and children: how many lives could be saved with targeted health interventions? PLoS Med (2010) 2.77

Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J Virol (2008) 2.72

Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. Int J Epidemiol (2011) 2.41

Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa. J Acquir Immune Defic Syndr (2010) 2.25

HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load. J Virol (2008) 2.14

Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial. Lancet (2005) 2.11

Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads. PLoS One (2008) 2.06

Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. J Virol (2010) 1.97

Time to implement 9-month infant HIV testing in South Africa. S Afr Med J (2015) 1.97

High incidence of unplanned pregnancy after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa. PLoS One (2012) 1.96

Health system weaknesses constrain access to PMTCT and maternal HIV services in South Africa: a qualitative enquiry. AIDS Res Ther (2011) 1.96

High pregnancy intentions and missed opportunities for patient-provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy. AIDS Behav (2012) 1.83

Role of traditional birth attendants in preventing perinatal transmission of HIV. BMJ (2002) 1.72

Eliminating mother-to-child HIV transmission in South Africa. Bull World Health Organ (2012) 1.64

Strengthening families to support children affected by HIV and AIDS. AIDS Care (2009) 1.64

Differential immunogenicity of HIV-1 clade C proteins in eliciting CD8+ and CD4+ cell responses. J Infect Dis (2005) 1.58

Excellent can be the enemy of good: the case of diarrhoea management. Lancet (2013) 1.52

Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? AIDS (2005) 1.41

Effectiveness of the WHO/UNICEF guidelines on infant feeding for HIV-positive women: results from a prospective cohort study in South Africa. AIDS (2007) 1.39

Implications of acquired environmental enteric dysfunction for growth and stunting in infants and children living in low- and middle-income countries. Food Nutr Bull (2013) 1.38

Operational effectiveness of single-dose nevirapine in preventing mother-to-child transmission of HIV. Bull World Health Organ (2007) 1.34

Targeting AIDS orphans and child-headed households? A perspective from national surveys in South Africa, 1995-2005. AIDS Care (2008) 1.33

An effectiveness study of an integrated, community-based package for maternal, newborn, child and HIV care in South Africa: study protocol for a randomized controlled trial. Trials (2011) 1.33

A systematic review on the meaning of the concept 'AIDS Orphan': confusion over definitions and implications for care. AIDS Care (2008) 1.28

Implications of the new WHO guidelines on HIV and infant feeding for child survival in South Africa. Bull World Health Organ (2010) 1.26

Breastfeeding, HIV status and weights in South African children: a comparison of HIV-exposed and unexposed children. AIDS (2010) 1.22

Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study. J Int AIDS Soc (2011) 1.22

Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants. J Virol (2007) 1.21

Impact of HLA in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection. J Virol (2009) 1.20

Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine. J Infect Dis (2005) 1.20

The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. Lancet Infect Dis (2007) 1.19

Goodstart: a cluster randomised effectiveness trial of an integrated, community-based package for maternal and newborn care, with prevention of mother-to-child transmission of HIV in a South African township. Trop Med Int Health (2014) 1.18

Use of antiretroviral drugs to prevent HIV-1 transmission through breast-feeding: from animal studies to randomized clinical trials. J Acquir Immune Defic Syndr (2004) 1.16

Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics. PLoS One (2010) 1.12

Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis. AIDS (2014) 1.07

"They told me to come back": women's antenatal care booking experience in inner-city Johannesburg. Matern Child Health J (2013) 1.05

Staphylococcus aureus bacteraemia at two academic hospitals in Johannesburg. S Afr Med J (2006) 1.05

Early cessation of breastfeeding amongst women in South Africa: an area needing urgent attention to improve child health. BMC Pediatr (2012) 1.04

Women's morbidity and mortality in the first 2 years after delivery according to HIV status. AIDS (2010) 1.03

Reported physical and sexual abuse in childhood and adult HIV risk behaviour in three African countries: findings from Project Accept (HPTN-043). AIDS Behav (2014) 1.01

Eliminating mother to child transmission of HIV-1 and keeping mothers alive: recent progress. J Infect (2013) 0.99

Children affected by HIV/AIDS: SAFE, a model for promoting their security, health, and development. Psychol Health Med (2010) 0.99

Towards a family-centered approach to HIV treatment and care for HIV-exposed children, their mothers and their families in poorly resourced settings. Future Virol (2011) 0.98

Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Int J Infect Dis (2003) 0.95

Is Option B+ the best choice? Authors' reply. Lancet (2013) 0.94

Timing of maternal HIV testing and uptake of prevention of mother-to-child transmission interventions among women and their infected infants in Johannesburg, South Africa. J Acquir Immune Defic Syndr (2014) 0.93

Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial. J Acquir Immune Defic Syndr (2014) 0.93

Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS. N Engl J Med (2004) 0.91

The role of quality improvement in achieving effective large-scale prevention of mother-to-child transmission of HIV in South Africa. AIDS (2015) 0.90

HIV disease progression in the first year after delivery among African women followed in the HPTN 046 clinical trial. J Acquir Immune Defic Syndr (2013) 0.90

Rare HLA drive additional HIV evolution compared to more frequent alleles. AIDS Res Hum Retroviruses (2009) 0.88

Drug resistance and coreceptor usage in HIV type 1 subtype C-infected children initiating or failing highly active antiretroviral therapy in South Africa. AIDS Res Hum Retroviruses (2011) 0.87

Short communication: CD4 counts of HIV-infected pregnant women and their infected children--implications for PMTCT and treatment programmes. Trop Med Int Health (2007) 0.87

A Political and Social History of HIV in South Africa. Curr HIV/AIDS Rep (2015) 0.86

Low Receipt and Uptake of Safer Conception Messages in Routine HIV Care: Findings From a Prospective Cohort of Women Living With HIV in South Africa. J Acquir Immune Defic Syndr (2016) 0.84

Extended prophylaxis with nevirapine and cotrimoxazole among HIV-exposed uninfected infants is well tolerated. AIDS (2012) 0.83

Delivering pediatric HIV care in resource-limited settings: cost considerations in an expanded response. AIDS (2013) 0.82

The obstetric face and challenge of HIV/AIDS. Clin Obstet Gynecol (2009) 0.82

High HIV incidence or poor test performance? AIDS (2009) 0.80

Vertical HIV transmission in South Africa: translating research into policy and practice. Lancet (2002) 0.79

Using mobile technology to improve maternal, child and youth health and treatment of HIV patients. S Afr Med J (2015) 0.78

Progress towards the millennium development goals in SA. S Afr Med J (2014) 0.78

Adolescents and HIV in sub-Saharan Africa: a timely issue and missed opportunity. Clin Infect Dis (2010) 0.78

Correction: Impact of Maternal HIV Seroconversion during Pregnancy on Early Mother to Child Transmission of HIV (MTCT) Measured at 4-8 Weeks Postpartum in South Africa 2011-2012: A National Population-Based Evaluation. PLoS One (2015) 0.77

Integrating tuberculosis services into a PMTCT HIV programme in South Africa. Int J Tuberc Lung Dis (2013) 0.77

Severe events in the first 6 months of life in a cohort of HIV-unexposed infants from South Africa: effects of low birthweight and breastfeeding status. Trop Med Int Health (2014) 0.77

The versatile lymphocyte count. Lancet (2004) 0.75

[In Process Citation]. S Afr Med J (2015) 0.75

Correction: Cost and Impact of Voluntary Medical Male Circumcision in South Africa: Focusing the Program on Specific Age Groups and Provinces. PLoS One (2017) 0.75

Efavirenz conceptions and regimen management in a prospective cohort of women on antiretroviral therapy. Infect Dis Obstet Gynecol (2012) 0.75

Primary level after-hours health services for children. S Afr Med J (2002) 0.75

Tracking antenatal HIV prevalence in South Africa. S Afr Med J (2015) 0.75

Evidence of AIDS mortality from an alternative source: A Swaziland case study. Afr J AIDS Res (2002) 0.75

Support for relactation among mothers of HIV-infected children: a pilot study in Soweto. Breastfeed Med (2014) 0.75

Hoosen Coovadia: an icon of South African health. Interview by Clare Kapp. Lancet (2009) 0.75

Roundtable. Revisiting the role of single-dose nevirapine for preventing perinatal HIV transmission. AIDS Clin Care (2005) 0.75

Introduction of Routine HIV Birth Testing in the South African National Consolidated Guidelines. Pediatr Infect Dis J (2017) 0.75

Viraemia before, during and after pregnancy in HIV-infected women on antiretroviral therapy in rural KwaZulu-Natal-South Africa, 2010-2015. Trop Med Int Health (2017) 0.75

Top stories of 2004. Perinatal transmission interventions: the benefits come with resistance. AIDS Clin Care (2005) 0.75